CVS Health Foundation Invests $2.6M to Enhance Maternal Health in NYC Communities
- CVS Health Foundation announced a $2.6 million grant to enhance maternal health initiatives in New York City.
- The initiative will expand to address rising gestational diabetes rates, benefiting more pregnant women and new mothers.
- CVS Health aims to improve healthcare access and outcomes for underserved communities through its maternal health commitment.
CVS Health Foundation Commits to Expanding Maternal Health Initiative in New York City
The CVS Health Foundation is making a significant impact on maternal healthcare in New York City with its recent announcement of a $2.6 million grant to the American Diabetes Association (ADA). This funding is set to enhance an existing maternal health initiative, specifically aimed at improving care for pregnant women and new mothers who are at risk of gestational diabetes (GDM). Over the past 18 months, the initiative has already seen success at Wyckoff Heights Medical Center in Brooklyn, where it has improved screening and care coordination for hundreds of patients. The expansion of this program will allow it to reach two additional communities, with a goal of addressing the rising GDM rates, which have increased from 6% in 2016 to 8.3% in 2021, according to CDC data.
The initiative particularly focuses on communities that report alarming diabetes statistics, such as Bushwick, where 19% of adults are affected by the condition. Furthermore, avoidable hospitalizations in this area are 70% higher than the city average, indicating a pressing need for improved healthcare services. Wyckoff Heights Medical Center itself highlights these concerns, with over 20% of its patients having diabetes and 56% showing dangerously high A1C levels above 9%. Through the CVS Health Foundation's generous grant, the ADA aims to replicate its proven model of care that has already benefitted many families in the region, providing comprehensive support throughout the prenatal and postpartum journey.
Jenny McColloch, President of the CVS Health Foundation, emphasizes the importance of this partnership in improving maternal health outcomes and fostering healthier futures for mothers and their children. Dr. Osagie Ebekozien from the ADA reinforces this sentiment, noting that the initiative has significantly enhanced access to maternal health services and diabetes support. By expanding this program, CVS Health and the ADA are taking critical steps to address healthcare disparities and improve the lives of at-risk populations in New York City.
In other developments, the CVS Health Foundation continues to prioritize initiatives that address social determinants of health, with a focus on underserved communities. The foundation's commitment to maternal health reflects its broader mission to promote health equity and improve access to quality care for all individuals, regardless of their circumstances. The foundation's initiatives are a testament to CVS Health's ongoing dedication to improving healthcare outcomes on a local and national scale.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

